Results 231 to 240 of about 330,139 (381)

Biometrical genetics [PDF]

open access: yesHeredity, 1972
K. Mather, J. L. Jinks
openaire   +1 more source

Enabling pandemic‐resilient healthcare: Narrowband Internet of Things and edge intelligence for real‐time monitoring

open access: yesCAAI Transactions on Intelligence Technology, EarlyView.
Abstract The Internet of Things (IoT) in deploying robotic sprayers for pandemic‐associated disinfection and monitoring has garnered significant attention in recent research. The authors introduce a novel architectural framework designed to interconnect smart monitoring robotic devices within healthcare facilities using narrowband Internet of Things ...
Md Motaharul Islam   +9 more
wiley   +1 more source

BAHGRF3: Human gait recognition in the indoor environment using deep learning features fusion assisted framework and posterior probability moth flame optimisation

open access: yesCAAI Transactions on Intelligence Technology, Volume 10, Issue 2, Page 387-401, April 2025.
Abstract Biometric characteristics are playing a vital role in security for the last few years. Human gait classification in video sequences is an important biometrics attribute and is used for security purposes. A new framework for human gait classification in video sequences using deep learning (DL) fusion assisted and posterior probability‐based ...
Muhammad Abrar Ahmad Khan   +7 more
wiley   +1 more source

Biometric identification [PDF]

open access: bronze, 2000
Anil K. Jain, Hong Lin, Sharath Pankanti
openalex   +1 more source

Automated craniofacial biometry with 3D T2w fetal MRI. [PDF]

open access: yesPLOS Digit Health
Matthew J   +17 more
europepmc   +1 more source

Voice biometrics [PDF]

open access: bronze, 2000
Judith Markowitz
openalex   +1 more source

Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Japanese Patients With Plaque Psoriasis: In‐Depth Analysis of Efficacy and Safety in the Phase 3 POETYK PSO‐4 Trial

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, is approved in Japan for adults with plaque, generalized pustular, and erythrodermic psoriasis who have inadequate response to conventional systemic therapies. In the Phase 3, open‐label POETYK PSO‐4 (NCT03924427) trial, deucravacitinib was efficacious and well ...
Yukari Okubo   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy